Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 3 Histomorphological evaluation of the segmental defect healing.

Published byMerilyn O’Connor’ Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 3 Histomorphological evaluation of the segmental defect healing."— Presentation transcript:

1 Fig. 3 Histomorphological evaluation of the segmental defect healing.
Histomorphological evaluation of the segmental defect healing. (A to D) Safranin Orange/von Kossa–stained thin section of a representative tibia sample in the mid-sagittal plane from each group; additional images are given in fig. S4. Scale bars, 10 mm. La, lateral; Me, medial; Pr, proximal; Di, distal, contralateral to the plate. (E) Sample harvested within the first weeks after surgery used as a control. The augmentation of the honeycombs with autologous cancellous bone graft (ABG) (remnants stained in black; marked with a blue star) and a prominent osteotomy hematoma in the central hole of the scaffold (white star) are still visible. Anne-Marie Pobloth et al., Sci Transl Med 2018;10:eaam8828 Published by AAAS

Download ppt "Fig. 3 Histomorphological evaluation of the segmental defect healing."

Similar presentations

Fig. 1. TP is highly expressed in myeloma.

Fig. 1. TP is highly expressed in myeloma.
Fig. 3. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures.

Fig. 3. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures.
Long-term periarticular bone adaptation in a feline knee injury model for post-traumatic experimental osteoarthritis  S.K. Boyd, Ph.D., R. Müller, Ph.D.,

Long-term periarticular bone adaptation in a feline knee injury model for post-traumatic experimental osteoarthritis  S.K. Boyd, Ph.D., R. Müller, Ph.D.,
Med Princ Pract 2016;25: DOI: /

Med Princ Pract 2016;25: DOI: /
Fig. 4. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin expression. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin.

Fig. 4. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin expression. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin.
Fig. 6. Ex vivo and in vivo test to evaluate the sealing capability of the MeTro sealant using a porcine lung incision model. Ex vivo and in vivo test.

Fig. 6. Ex vivo and in vivo test to evaluate the sealing capability of the MeTro sealant using a porcine lung incision model. Ex vivo and in vivo test.
Fig. 2. Bestatin treatment improves tail anatomy and restores lymphatic function. Bestatin treatment improves tail anatomy and restores lymphatic function.

Fig. 2. Bestatin treatment improves tail anatomy and restores lymphatic function. Bestatin treatment improves tail anatomy and restores lymphatic function.
Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,

Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
Fig. 1. BCAS1 expression identifies newly generated oligodendrocytes.

Fig. 1. BCAS1 expression identifies newly generated oligodendrocytes.
Fig. 1 Finite element model and calculations.

Fig. 1 Finite element model and calculations.
Fig. 4. Biomechanical properties of treated tibiae.

Fig. 4. Biomechanical properties of treated tibiae.
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.

Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.
Fig. 6. N95BA5 biocompatibility beyond intended use frame.

Fig. 6. N95BA5 biocompatibility beyond intended use frame.
Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.
Fig. 4. Prion infectivity of skin samples from sCJD patients.

Fig. 4. Prion infectivity of skin samples from sCJD patients.
Fig. 4 Infection-induced CLV dysfunction is associated with decreased LMC coverage. Infection-induced CLV dysfunction is associated with decreased LMC.

Fig. 4 Infection-induced CLV dysfunction is associated with decreased LMC coverage. Infection-induced CLV dysfunction is associated with decreased LMC.
Fig. 4. Characterization of human liver seed graft morphology.

Fig. 4. Characterization of human liver seed graft morphology.
Fig. 4 Bone tissue formation within the Ti-mesh channels.

Fig. 4 Bone tissue formation within the Ti-mesh channels.
Fig. 7. The PD-L1 defect is evident in HSPCs from T1D patients.

Fig. 7. The PD-L1 defect is evident in HSPCs from T1D patients.

Similar presentations

Ads by Google